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Abstract
 
Four pancreatic islet-specific CD4
 
1
 
 helper T (Th) 1 (Th1)
clones and two Th1 clones transduced with an SR
 
a
 
 pro-
moter-linked murine IL-10 (mIL-10) cDNA of 2.0–6.0 
 
3
 
 10
 
6
 
cells were adoptively transferred to nonobese diabetic
(NOD) mice at age 8 d. Cyclophosphamide (CY) was ad-
ministered at age 37 d (plus CY), and the incidence of dia-
betes and the histological grade of insulitis were examined
at age 47 d. After the adoptive transfer of IL-10–transduced
Th1 cells, polymerase chain reaction (PCR) and reverse-
transcription (RT)-PCR detected the neo gene and the ret-
rovirus vector-mediated IL-10 mRNA in situ in recipient is-
lets, respectively. RT-PCR detected the decrease of IFN-
 
g
 
mRNA relative to IL-10 mRNA in IL-10–transduced Th1
clones in vitro and also in recipient islets. All four wild type
Th1 clones plus CY induced the insulitis grade of 2.75 and
diabetes in 66% of recipient NOD mice. IL-10–transduced
two Th1 clones plus CY induced periinsulitis with the grade
of 1.43 and diabetes in 8.0%. The 1:1 mixture of wild type
Th1 cells and IL-10–transduced Th1 cells plus CY induced
periinsulitis with the grade of 1.85 and diabetes in 20%. The
suppression of diabetes through decreasing IFN-
 
g
 
 mRNA
by the tissue-specific delivery of IL-10 to pancreatic islets
with IL-10–transduced Th1 cells affords us the starting ba-
sis to develop the gene therapy for autoimmune diabetes. (
 
J.
Clin. Invest. 
 
1996. 98:1851–1859.) Key words: insulin-
dependent diabetes mellitus 
 
•
 
 insulitis 
 
•
 
 Th2 
 
•
 
 pancreatic is-
let B cells (islet B-cells) 
 
•
 
 somatic gene therapy
 
Introduction
 
Nonobese diabetic (NOD)
 
1
 
 mice are an animal model of insu-
lin-dependent diabetes mellitus resulting from autoimmune
destruction of pancreatic islet B-cells (islet B-cells). Diabetes
in NOD mice is preceded by insulitis consisting mostly of T
cells (1). Direct evidence for both autoimmunity and T cell in-
volvement in insulitis and diabetes in NOD mice has been pro-
vided by T cell ablation and adoptive transfer experiments. Di-
abetes can be transferred to NOD mice by splenocytes (2),
bone marrow cells (3, 4), or purified T cell subpopulation (5, 6)
of diabetic NOD mice. Although both CD4
 
1
 
 and CD8
 
1
 
 T cell
subsets were shown to be involved (5, 6), islet-specific CD4
 
1
 
Th clones (7, 8) or CD8
 
1
 
 clones (9) alone could transfer diabe-
tes to NOD mice.
The immunological signals of self-reacting Th cells are reg-
ulated in part by IFN-
 
g
 
, IL-10, and other cytokines. IL-1, TNF-
 
a
 
,
-
 
b
 
, and IFN-
 
g
 
 were shown to directly destroy islet B-cells, and
inhibit insulin secretion in vitro (10–12). Transgenic expression
of IFN-
 
g
 
 or -
 
a
 
 in islet B-cells induced autoimmune insulitis
and diabetes in non-NOD mice (13, 14). On the other hand,
systemic administration of IL-2, -4, -10, or even cytotoxic cy-
tokines of IL-1, TNF-
 
a
 
, and -
 
b
 
 protected NOD mice and other
animal models of insulin-dependent diabetes mellitus from be-
coming diabetic (15–20). The systemic administration of anti–
IFN-
 
g
 
, -
 
a
 
, or IL-6 monoclonal antibody protected the onset of
diabetes in NOD mice (21, 22).
Two types of Th cells, Th1 and Th2, with distinct cytokine
secretion patterns, have been described both in mice (23, 24)
and humans (25, 26). IL-10 derived mainly from Th2 inhibits
macrophage-dependent antigen (Ag) presentation, Ag-spe-
cific T cell proliferation, and production of IFN-
 
g
 
 by Th1 in
vitro (27). These findings suggest that IL-10 inhibits autoim-
mune diabetes in vivo. On the other hand, transgenic expres-
sion of IL-10 in islet A- or B-cells in NOD mice aggravated in-
sulitis and accelerated the onset of diabetes (28, 29).
To deliver IL-10 to pancreatic islets in vivo and to test its
local effects on the immunological destruction of islet B-cells
in NOD mice, we tried to use islet-specific Th1 clones (30) as a
vehicle to deliver IL-10 to pancreatic islets. After the adoptive
transfer of wild type Th1 clones, IL-10–transduced Th1 cells,
or the mixture of the two to neonatal NOD mice, IL-10 and
IFN-
 
g
 
 mRNA levels in recipient islets, the incidence of diabe-
tes, and the histological grades of insulitis were examined.
 
Methods
 
Th1 clones and maintenance. 
 
Four islet-specific Th1 clones named
7-10–D.3, 4-1–G.4, 4-1–K.1, and 4-1–L.6 (abbreviated as D, G, K, and
L), in which the IFN-
 
g
 
 mRNA was detected by the RT-PCR analysis
(Fig. 1), were established from infiltrating T cells within islets of 7–11
wk-old NOD mice (30). These four Th1 clones having different T cell
receptor (TCR) repertoires (30) were maintained in RPMI-1640 with
10
 
2
 
5
 
 M 
 
b
 
-mercaptoethanol and 10% fetal bovine serum (Hyclone,
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Logan, UT). Growth of the Th1 clones was stimulated by culturing 1
 
3
 
 10
 
6
 
 cells of each clone with 1 
 
3
 
 10
 
5
 
 irradiated dispersed NOD islet
cells as Ag, 1 
 
3
 
 10
 
7
 
 irradiated NOD splenocytes as Ag-presenting
cells (APCs), and 20 U/ml of recombinant mIL-2 (Becton Dickinson,
Bedford, MA) in a 25 cm
 
2
 
 culture flask with 5 ml of culture medium.
To obtain 2 
 
3
 
 10
 
6
 
 islet cells, the pancreata of eight NOD mice were
perfused with collagenase (1 mg/ml; Nitta Gelatin, Osaka, Japan) dis-
solved in HBSS followed by the incubation at 37
 
8
 
C for 30 min (30).
Islets were washed three times with HBSS, and placed in a discontin-
uous density gradient of Ficoll (model Ficoll-400; Pharmacia Fine
Chemicals, Uppsala, Sweden) at 25, 23, 21, and 15%. After centrifu-
gation at 850 
 
g
 
, islets were removed from 15–21% and 21–23% inter-
face, washed with RPMI-1640, and dispersed into single cells in
0.02% EDTA solution (Nakalai Tesque, Kyoto, Japan). The cells
were irradiated with 3,000 rad from a 
 
60
 
Co source and resuspended in
culture medium. Splenocytes from 2 NOD mice were filtered through
a cell sieve of a 200 
 
m
 
m mesh size, resuspended in RPMI-1640, and
centrifuged at 400 
 
g.
 
 After washing, splenocytes were similarly irradi-
ated, resuspended in RPMI-1640, and used as APCs. Th1 clones were
restimulated every 10 d with Ag and APC.
 
RT-PCR detection of IL-10, -2, -4, and IFN-
 
g
 
 mRNA. 
 
200 mg/kg
body weight (BW) of CY (Shionogi, Osaka, Japan) was administered
i.p. at age 37 d (plus CY) in the adoptive transfer experiment. Total
RNA was isolated from wild type Th1 clones, IL-10–transduced Th1
cells, and recipient islets after the adoptive transfer of wild type Th1
clones plus CY or IL-10–transduced Th1 cells plus CY with the
guanidium isothiocyanate-phenol-chloroform procedure. Total RNA
in 1 
 
m
 
g treated with RNase-free DNase (Promega Corp., Madison,
WI) was reverse-transcribed with 100 U of Moloney Murine Leuke-
mia Virus (Mo-MLV) reverse transcriptase (RTase) (Promega
Corp.) and 100 pM of random hexamer primers (Pharmacia Fine
Chemicals) in 20 
 
m
 
l of RT-reaction buffer containing 0.5 mM each of
dNTPs, 1 mM dithiothreitol, and 20 U of RNasin (Promega Corp.).
After incubation at 37
 
8
 
C for 1 h, the reaction mixture was heated at
95
 
8
 
C for 5 min, and cDNA was stored at 
 
2
 
20
 
8
 
C until use. The mRNAs
for IL-10, -2, -4, and IFN-
 
g
 
 were first PCR-amplified from 1 
 
m
 
l of syn-
thesized cDNA in a total volume of 20 
 
m
 
l to a plateau level at 42 cy-
cles (Figs. 1 and 2). The IL-10 and IFN-
 
g
 
 mRNAs were then ampli-
fied every five cycles from 25 to 40 cycles for the semiquantitative
RT-PCR cycle number analysis (Fig. 3). Each PCR cycle included de-
naturation at 94
 
8
 
C for 1 min, annealing at 56
 
8
 
C for 1 min, and exten-
sion at 72
 
8
 
C for 2 min, with the final extension for 8 min. PCR prod-
ucts were electrophoresed on an 8% polyacrylamide gel. Pairs of
primers used to amplify cytokine mRNAs and 
 
b
 
-actin mRNA as an
internal control were listed in Table I. Those for IL-10 included two
pairs of “A” to detect the retrovirus vector-mediated IL-10 mRNA
and two pairs of “B” to detect total IL-10 mRNA including both the
retrovirus vector-mediated and endogenous IL-10 mRNAs. All
primer pairs were designed in separate exons to cross an intron. The
RT-PCR analyses of two different mRNA preparations each for cul-
tured wild type Th1 clones plus CY or IL-10–transduced Th1 cells
plus CY, and three different recipient islet preparations each after the
adoptive transfer of wild type Th1 clones plus CY or IL-10–trans-
duced Th1 cells plus CY were all repeated at least three times, respec-
tively.
 
Construction of a retroviral vector.
 
A 5.2 kbp retroviral vector
construct of pBabe Neo (31) containing the Mo-MLV long terminal
repeats (LTRs) and the neomycin phosphotransferase gene was used
to transduce wild type Th1 clones with mIL-10 cDNA. An SR
 
a
 
 pro-
moter sequence (32) of 640 bp was cut out with Hind III and Xho I
from an F115 plasmid provided by K.W. Moore (DNAX Research
Institute of Molecular Biology, Palo Alto, CA). This SR
 
a
 
 promoter
sequence was inserted into a SnaB I site of a pBabe Neo vector after
blunt-ending with T4 DNA polymerase (pRB501). A 600 bp Sac I
Figure 1. RT-PCR detection of cytokine mRNAs in wild type Th1 
clones and IL-10–transduced Th1 cells. Ethidium bromide-stained 
polyacrylamide gels showing RT-PCR–amplified fragments with each 
pair of primers for IL-10, -2, -4, IFN-g, and b-actin mRNA are pre-
sented. (A) Total RNA in 1 mg isolated from Th1 clones was reverse-
transcribed using random primers. Lane M in all figures shows a 
DNA size marker of Hae III-digested fX174. Lanes 1–5 show RT-
PCR-amplified fragments of total IL-10 (145 bp), IL-2 (230 bp), IL-4 
(399 bp), IFN-g (399 bp), and b-actin (245 bp) mRNA, respectively. 
The arrows indicate the RT-PCR–amplified fragments of IFN-g and 
b-actin mRNA. (B) Total RNA in 1 mg isolated from IL-10–trans-
duced Th1 cells was reverse-transcribed using random primers. Lanes 
1–5 are the same as in A. The arrows indicate the RT-PCR–amplified 
fragments of IFN-g, b-actin, and total IL-10 mRNA.
Figure 2. RT-PCR detection of IL-10 mRNA. Ethidium bromide-
stained polyacrylamide gels showing RT-PCR–amplified fragments 
of IL-10 and b-actin mRNA are presented. Total RNA in 1 mg iso-
lated from IL-10–transduced Th1 cells and recipient islets after the 
adoptive transfer of wild type Th1 clones plus CY or IL-10–trans-
duced Th1 cells plus CY was reverse-transcribed using random prim-
ers. (A) Lane 1, a 187 bp RT-PCR–amplified fragment of total IL-10 
mRNA from IL-10–transduced Th1 cells without RTase; lane 2, the 
same as lane 1 but with RTase. The arrow indicates the RT-PCR–
amplified fragment of total IL-10 mRNA. (B) Lanes 1 and 2, 134 and 
344 bp RT-PCR–amplified fragments of retrovirus vector-mediated 
IL-10 mRNA as indicated with arrows, respectively, from recipient is-
lets after the adoptive transfer of IL-10–transduced Th1 cells plus 
CY; lanes 3 and 4, the same as lanes 1 and 2 but from recipient islets 
after the adoptive transfer of wild type Th1 clones plus CY; lane N, 
template free. (C) Lanes 1 and 2, 245 bp RT-PCR-amplified fragment 
of b-actin, as indicated with an arrow, from recipient islets after the 
adoptive transfer of IL-10–transduced Th1 cells plus CY, and wild 
type Th1 clones plus CY, respectively.
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mIL-10 fragment was also cut out from an F115 plasmid, and sub-
cloned into an Eco RV site of pBluescript vector (pRB402). An Eco
RI and Sal I fragment from a pRB402 was then subcloned into an Eco
RI and Sal I site of pRB501. The resulting retroviral vector (pRB107)
contained a stretch of LTR/SR
 
a
 
/mIL-10 cDNA/and the neo gene
(Fig. 4).
 
Generation of G418
 
r
 
 packaging cells and G418
 
r
 
 Th1 clones. 
 
All
packaging cells were grown in DMEM with 10% FBS. An ecotropic
packaging cell line of 
 
c
 
CRE (33), was transfected with 10 
 
m
 
g of
pRB107 using the lipofectin reagent (GIBCO BRL, Gaithersburg,
MD) according to the manufacturer’s instruction. An amphotropic
packaging cell line of 
 
c
 
CRIP (33) was subsequently infected with vi-
ral particles in the culture supernatant of 
 
c
 
CRE cells, in the presence
of 8 
 
m
 
g/ml of polybrene (hexadimethrine bromide; Sigma Chemical
Co., St. Louis, MO) at 37
 
8
 
C for 1.5 h. After the exposure, cells were
washed with DMEM and cultured for 24 h. After splitting these cells
at the ratio of 1:20, cells were cultured for 14 d in the selection me-
dium containing G418 (GIBCO BRL) at 1 mg/ml by the active
weight. Virus titers in colony forming units (CFU)/ml of G418
 
r
 
-
 
c
 
CRIP clones were determined using NIH/3T3 cells, and mIL-10
concentrations were screened with the enzyme-linked immunosor-
bent assay (34). One clone of G418
 
r
 
-
 
c
 
CRIP–8 produced the highest
titer of 8 
 
3
 
 10
 
6
 
 CFU/ml. This clone which produced 10 U/ml of mIL-
10, with the others producing 5-10 U/ml in the culture medium, was
used to infect Th1 clones.
Th1 clones were exposed to 2–4 ml of the culture supernatant of
G418
 
r
 
-
 
c
 
CRIP–8 clone in the presence of 6 
 
m
 
g/ml of polybrene at 37
 
8
 
C
for 1.5 h, on the third day after Ag stimulation. After the exposure,
these cells were washed with RPMI-1640. Cells were cultured for 14 d
in the selection medium with G418 added at 0.3 mg/ml first on the
third day after transduction. IL-10–transduced Th1 cells were cul-
tured further for 14 d, while the concentration of G418 was gradually
increased to 0.45 mg/ml to select stable transformants. IL-10–trans-
duced Th1 cells produced 10 U/ml of mIL-10 on the third day after
Ag stimulation. G418
 
r
 
–IL-10–transduced D8 or G8 Th1 cells without
further cloning into separate clones were used for adoptive transfer
experiments of the 1:1 mixture with corresponding wild type Th1
clones.
 
Adoptive transfer. 
 
2.0–6.0 
 
3
 
 10
 
6
 
 Th1 cells of following types,
each in 200 ml of PBS were transferred i.p. to NOD mice at age 8 d.
When the 1:1 mixture of wild type Th1 clones and IL-10–transduced
Th1 cells were adoptively transferred, the cell number of wild and IL-
Figure 3. Semiquantitative 
RT-PCR cycle number anal-
ysis of IL-10 and IFN-g
mRNAs. Total RNA in 1 mg 
was reverse-transcribed us-
ing random primers. The 
ethidium bromide-stained 
polyacrylamide gels are pre-
sented. Lanes 1–4 or lanes 
5–8 correspond to RT-PCR 
cycle numbers of 25, 30, 35, 
and 40, respectively. (A) 
RNA was isolated from wild 
type Th1 clones or IL-10–
transduced Th1 cells. Lanes 
1–4 and lanes 5–8 show the 
RT-PCR–amplified 187 bp 
fragment of total IL-10 
mRNA in wild type and IL-
10–transduced Th1 cells, re-
spectively, as indicated with 
an arrow. Lanes 9–12 and 
lanes 13–16 show the RT-
PCR–amplified 195 bp frag-
ment of IFN-g mRNA in 
wild type and IL-10–trans-
duced Th1 cells, respec-
tively, as indicated with an 
arrow. (B) RNA was iso-
lated from recipient islets af-
ter the adoptive transfer of 
wild type Th1 clones plus 
CY or IL-10–transduced 
Th1 cells plus CY. Lanes
1–16 are the same as in A, 
except that recipient islets 
were used instead of cul-
tured Th1 cells. The bottom 
figures show the RT-PCR–
amplified 245 bp fragment 
of b-actin mRNA, as indi-
cated with an arrow, from 
the same samples in the 
same conditions shown in 
the figure above.
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10–transduced Th1 cells were always between 2.0–3.0 3 106, respec-
tively, to make the total number between 4.0–6.0 3 106 cells. Four dif-
ferent wild type Th1 clones of D, G, K, or L (9, 9, 8, or 9), IL-10–
transduced Th1 cells (six for D8, and six for G8), or the 1:1 mixture of
the wild type Th1 clones and IL-10–transduced Th1 cells (five for
wild type D 1 D8, and five for wild type G 1 G8) were adoptively
transferred to the number of mice shown in the parentheses. At age
37 d, 200 mg/kg BW of CY were administered i.p. At age 35 and 47 d,
blood was drawn from incised tails between 9:00 and 11:00 a.m. and
non fasting blood glucose (BG) concentrations were assayed using a
glucose analyzer (model DRI-CHEM 100; Fuji Photo Film Co.,
Kanagawa, Japan). Mice were considered diabetic when the nonfast-
ing BG concentration was above 250 mg/dl. At age 47 d, islet speci-
mens were sampled for histological analysis.
PCR detection of the neo gene. Genomic DNA was isolated from
wild type Th1 clones, IL-10–transduced Th1 cells, and paraffin-embed-
ded islet specimens. Pancreatic islets were first localized by micro-
scopic observation of hematoxylin and eosin-stained samples. Local-
ized islets in sections of 10 mm thickness were scraped from a slide
glass with a razor blade, placed in an Eppendorf tube, deparaffinized
by washing twice in xylene, twice in 95% ethanol, and dried under re-
duced pressure. The sample was digested overnight with proteinase K
(200 mg/ml) in 200 ml of digestion buffer including 1 3 saline-sodium
citrate, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, and 1% SDS at 378C.
After digestion and phenol-chloroform extraction, DNA samples
were introduced to PCRs. The neo gene fragment was PCR-amplified
after 35 cycles of denaturation at 948C for 1 min, annealing at 598C for
1 min, and extension at 728C for 2 min with the final extension for 10
min. Two sense and one antisense primers of oRB1264S (59-CAA-
GATGGATTACACGCAGG-39), oRB1266S (59-GGCGATGCCT-
GCTTGCCGAA-39), and oRB1265A (59-CCCGCTCAGAAGAA-
CTCGTC-39) were designed to yield a 791 or 236 bp PCR-amplified
fragment of the neo gene.
Histological analysis. Recipient mice and age- and sex-matched
control mice, six mice in each group, were killed at age 47 d, i.e., 39 d
after the adoptive transfer. The pancreas was excised and fixed in
3.7% formaldehyde, and processed for paraffin sectioning. Two- to
three-step sections of 3 mm separated by at least 30 mm were stained
with hematoxylin and eosin, and more than 20 islets per mouse were
analyzed by an uninformed pathologist. The histological grades of in-
sulitis were evaluated for individual islets using the following criteria
of 0 to 3: 0, intact islet without any infiltration; 1, infiltration sur-
rounding or involving less than 25% of the islet area; 2, infiltration in-
volving between 25 and 50% of the islet area; and 3, infiltration in-
volving more than 50% of the islet area.
Statistical analysis. The percentage distribution of islets among
four histological insulitis grades of 0 to 3 and the mean histological
grade of insulitis in specimens of each mouse were first calculated.
The mean percentage distribution of islets among four insulitis grades
and the mean histological grade6SD of insulitis in each group were
then calculated. Student’s unpaired t test was used for the statistical
analysis. P , 0.05 was considered significant.
Results
RT-PCR detection of cytokine mRNA. The IFN-g mRNA,
but not mRNA of IL-2, -4, or -10 was detected with the RT-
PCR analysis of the wild type Th clones (Fig. 1 A). Four Th
clones were thus shown to belong to the Th1 subtype. After
transfecting cCRIP packaging cells with the retroviral con-
struct with lipofectin, 34 G418r-cCRIP packaging clones were
selected and titered. The titers of these clones were from 1 3
Table I. Sequences of PCR Primer Pairs Used to Amplify mRNAs of Cytokines and b-actin
Forward primer
Reverse primer
Sequence
Sequence
Target
(Fragment size) (bp)
oRB1715S 59-GCCTGACCCTGCTTGCTCAA-39 IL-10 (A)* (344)
oRB663A 59-CATTTCCGATAAGGCTTGG-39
oRB1715S (as above) IL-10 (A)* (134)
oRB515A 59-TCCTCATGCCAGTCAGTAAG-39
oRB632S 59-CGGGAAGACAATAACTGCA-39 IL-10 (B)‡ (187)
oRB633A (as above)
oRB1115S 59-ATGCGGCTGAGGCGCTGTCA-39 IL-10 (B)‡ (145)
oRB777A 59-CTATGCAGTTGATGAAGATG-39
oRB1387S 59-GCAGGATGGAGAATTACAGG-39 IL-2 (230)
oRB1388A 59-GTTGTCAGAGCCCTTTAGTTT-39
oRB1269S 59-ATGGGTCTCAACCCCCAGCTA-39 IL-4 (399)
oRB1270A 59-GCTCTTTAGGCTTTCCAGGAAGTC-39
oRB1271S 59-CACAGTCATTGAAAGCCTAG-39 IFN-g (399)
oRB1135A 59-GAATCAGCAGCGACTCCTTT-39
oRB1271S (as above) IFN-g (195)
oRB1134A 59-TTGCTGATGGCCTGATTGTC-39
oRB1634S 59-GTGGGCCGCTCTAGGCACCA-39 b-actin (245)
oRB1635A 59-CGGTTGGCCTTAGGGTTCAGG-39
All primers were designed in exons separated by an intron. *IL-10 (A) and ‡IL-10 (B) correspond to primer pairs to amplify a retroviral vector-medi-
ated IL-10 mRNA and total IL-10 mRNA including both retroviral vector-mediated and endogenous IL-10 mRNAs, respectively.
Figure 4. Schematic presentation of a retroviral vector construct. A 
5.2 kbp retroviral vector of pBabe Neo contains a stretch of Mo-MLV 
59 and 39-LTRs, an SRa promoter (640 bp), mIL-10 cDNA (600 bp), 
and the neomycin phosphotransferase gene (1165 bp).
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103 to 8 3 106 CFU/ml. After transduction of wild type Th1
clones with the supernatant of cCRIP-8, the proliferation of
IL-10–transduced Th1 cells did not change in comparison with
wild type Th1 clones after stimulation with Ag (data not
shown).
From IL-10–transduced Th1 cells of G8, a 145 (Fig. 1 B) or
187 (Fig. 2 A) bp PCR-amplified fragment of total IL-10
mRNA was detected, while a 399 bp PCR-amplified fragment
of IFN-g mRNA was retained (Fig. 1 B). No IL-10 mRNA
signals were detected from wild type Th1 clones (Fig. 1 A) or
after omitting RTase from the reaction mixture in IL-10-trans-
duced Th1 cells (Fig. 2 A). The retrovirus vector-mediated
IL-10 mRNA was detected as a 134 or 344 bp PCR-amplified
fragment from recipient islets after the adoptive transfer of IL-
10–transduced Th1 cells plus CY, while no signals were de-
tected from islets after the adoptive transfer of wild type Th1
clones plus CY (Fig. 2 B).
PCR detection of the neo gene. A 791 or 236 bp PCR-
amplified fragment of the neo gene was detected in IL-10–
transduced Th1 cells of G8 (Fig. 5 A). The 236 bp PCR-ampli-
fied neo gene fragment was not detected from wild type Th1
clones of D or G, although the PCR-amplified 375 bp b-actin
gene fragment was detected in all types of cells (Fig. 5 B). In
pancreatic specimens from two NOD mice of No. 1 and 2 after
the adoptive transfer of IL-10–transduced Th1 cells of G8 plus
CY, the 236 bp PCR-amplified fragment of the neo gene was
detected (Fig. 5 B). In contrast, the neo gene fragment was not
detected in pancreatic specimens of NOD mice after the adop-
tive transfer of wild type Th1 clones plus CY (data not shown).
RT-PCR cycle number analysis of IL-10 and IFN-g mRNAs.
To semi-quantitate the levels of IL-10 and IFN-g mRNAs in
wild type Th1 clones or IL-10–transduced Th1 cells in vitro,
cDNA produced from RNA was PCR-amplified at 25, 30, 35,
or 40 cycles (Fig. 3). The PCR cycle number greater than 30
was necessary to detect the 187 bp PCR-amplified fragment of
total IL-10 mRNA from IL-10–transduced Th1 cells (Fig. 3 A,
lanes 7 and 8), but it was not detected at any cycles from wild
type Th1 clones (Fig. 3 A, lanes 1–4). The 195 bp PCR-ampli-
fied fragment of IFN-g mRNA was observed from IL-10–
transduced Th1 cells after 35 cycles of PCR amplification (Fig.
3 A, lanes 15 and 16), while it was observed after 30 cycles of
PCR-amplification in wild type Th1 clones in the simultaneous
assessment (Fig. 3 A, lanes 10–12), which was confirmed by re-
peating at least three times for two different mRNA prepara-
tions.
Retrovirus vector-mediated IL-10 mRNA was specifically
detected from recipient islets after the adoptive transfer of IL-
10–transduced Th1 cells plus CY (Fig. 2 B). In the semi-quan-
titative RT-PCR cycle number analysis of recipient islets, the
187 bp PCR-amplified fragment of total IL-10 mRNA was de-
tected after 30 cycles of amplification at the comparable inten-
sity after the adoptive transfer of wild type Th1 clones plus CY
(Fig. 3 B, lanes 2–4) or IL-10–transduced Th1 cells plus CY
(Fig 3 B, lanes 6–8). On the other hand, IFN-g mRNA was de-
tected after 35 cycles in recipient islets after the adoptive trans-
fer of IL-10–transduced Th1 cells plus CY (Fig. 3 B, lanes 15
and 16), while it was clearly detected at 30 cycles in recipient
islets after the adoptive transfer of wild type Th1 clones plus
CY (Fig. 3 B, lanes 10–12), which was confirmed by repeating
at least three times for three different recipient islet prepara-
tions. Thus, the level of IFN-g mRNA and its relative level to
IL-10 mRNA were decreased in recipient islets after the adop-
tive transfer of IL-10–transduced Th1 cells. b-actin mRNA as
a control was consistently detected and the amplified bands
showed the cycle number-dependent increase in their intensi-
ties. The intensities of the b-actin bands were, however, com-
parable in all tested conditions.
Incidence of diabetes after adoptive transfer. The adoptive
transfer of four different Th1 clones plus CY, respectively,
transferred diabetes to non-diabetic NOD mice (Fig. 6). The
incidence of diabetes (the number of diabetic mice/the total
number of examined mice) at age 47 d for each of four clones
of D, G, K, or L, was comparable in 78 (7/9), 67 (6/9), 63 (5/8),
or 56% (5/9), respectively, and the mean incidence of diabetes
was 66% (23/35) in total. Th1 clones by themselves without
CY administration (minus CY) induced diabetes in 5% (2/39).
CY administration alone did not induce diabetes (0/22). There
was no incidence of diabetes in control NOD mice with the ad-
ministration of PBS alone (0/25).
The adoptive transfer of IL-10–transduced Th1 cells plus
CY remarkably decreased the cumulative incidence of diabe-
tes from 66% observed after the adoptive transfer of wild type
Th1 clones plus CY down to 8% (1/12) (Fig. 6). The incidence
after the adoptive transfer of the 1:1 mixture of wild type Th1
clones and corresponding IL-10–transduced Th1 cells of wild
type D 1 D8 plus CY, or wild type G 1 G8 plus CY was 0 (0/5)
or 40% (2/5), respectively, making an incidence of 20% (2/10)
in total (Fig. 6).
Histological analysis of pancreatic islets. To quantitatively
assess the histological grade of insulitis, pancreatic islets of six
NOD mice, each a control mouse, CY administration alone,
after the adoptive transfer of wild type Th1 clones plus or mi-
nus CY, IL-10–transduced Th1 cells plus CY, and the 1:1
Figure 5. PCR-detection of the Neo gene. DNA was extracted from 
wild type Th1 clones, IL-10–transduced Th1 cells, and two recipient 
islet preparations from mouse No. 1 or 2 after the adoptive transfer of 
IL-10–transduced Th1 cells plus CY. The neo gene fragment was 
PCR-amplified and the ethidium bromide-stained polyacrylamide 
gels are presented. (A) Genomic DNA from IL-10–transduced Th1 
cells was used as a template. Lanes 1 and 2, amplification of the 791 
and 236 bp neo gene fragments, respectively, as indicated with ar-
rows. (B) Lanes 1 and 2, islet DNA from mouse No. 1; lanes 3 and 4, 
islet DNA from mouse No. 2; lanes 5–7, DNA from wild type Th1 
clones; and lane N, template free. Lanes 1 and 3 show the PCR-ampli-
fied 236 bp neo gene fragment as indicated with an arrow; lanes 2, 4, 
and 7 show the PCR-amplification of the 375 bp b-actin gene frag-
ment as a control, as indicated with an arrow.
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mixture of wild type Th1 clones and the corresponding IL-
10–transduced Th1 cells plus CY were graded for the severity
of insulitis according to our criteria. As shown in Table II, the
mean histological grade of insulitis in control NOD mice with-
out adoptive transfer, CY administration alone, or adoptive
transfer of wild type Th1 clones minus CY was 0.48, 0.98, or
1.85, respectively, with the parallel shift in the percentage dis-
tribution of islets among four insulitis grades (Table II). Most
islets of NOD mice after the adoptive transfer of wild type Th1
clones plus CY exhibited advanced insulitis of grade three
(Fig. 7, A and B) with the mean grade of 2.75, while acinar
cells around islets were intact. In contrast, most islets of NOD
mice after the adoptive transfer of IL-10–transduced Th1 cells
plus CY exhibited periinsulitis or insulitis of grade one (Fig. 7,
C and D) with the mean grade of 1.43, which was significantly
lower than 2.75 after the adoptive transfer of wild type Th1
clones plus CY (P , 0.0001). The islets of recipient NOD mice
after the adoptive transfer of the 1:1 mixture of both types of
cells plus CY exhibited insulitis with the mean grade of 1.85
which was significantly lower than 2.75 after the adoptive
transfer of wild type Th1 clones plus CY (P , 0.001), but with-
out significant difference from that after the adoptive transfer
of IL-10–transduced Th1 cells plus CY. The suppression of
mean insulitis grade after the adoptive transfer of IL-10–trans-
duced Th1 cells plus CY or the mixture of the two plus CY was
associated with the parallel downward shift in the percentage
distribution of islets among four insulitis grades.
Discussion
IL-10 in its large part is an immunosuppressive cytokine for
macrophages and Th1 lymphocytes (27), which is in sharp con-
Table II. Distribution of Islets Among Four Insulitis Grades
Group No. Treatment conditions
Number
of mice
Percentage distribution
among insulitis grades
Mean grade
6SD
Number
of islets
P-value
(Gr. No.*)0 1 2 3
1. Control 6 53.5 44.9 1.6 0 0.48 168 0.0001 (5)
(2 CY) 60.17 0.0005 (6)
2. CY only 6 15.8 70.8 13.4 0 0.98 152 0.0005 (1)
60.16 0.0001 (4)
3. D, G, K, or L 6 0.6 47.7 27.8 23.9 1.85 192 0.0001 (1)
clone (2 CY) 60.29 0.0005 (2)
4. D, G, K, or L 6 0 1.7 21.6 76.7 2.75 122 0.0001 (3)
clone (1 CY) 60.12 0.001  (6)
5. IL-10–transduced 6 2.4 62.7 24.4 10.5 1.43 192 0.005  (2)
D8 or G8 cells (1 CY) 60.24 0.0001 (4)
6. D or G clone 1 6 0 46.9 30.4 22.7 1.85 137 0.005 (2)
D8 or G8 cells (1 CY) 60.50 50.181(5)
Group No. 1 and 2 denote age- and sex-matched NOD mice without adoptive transfer, and those with CY administration alone, respectively. Group
No. 3 and 4 denote those after the adoptive transfer of wild type Th1 clones minus CY and plus CY, respectively. Group No. 5 denotes those after the
adoptive transfer of IL-10–transduced Th1 cells plus CY, and Group No. 6 denotes those with the adoptive transfer of the 1:1 mixture of wild type D
or G clones and corresponding IL-10–transduced Th1 cells of D8 or G8 clone, respectively, plus CY. P-value denotes the significance level in Stu-
dent’s unpaired t test with data of the group No. indicated in parentheses.
Figure 6. Time course of the incidence of diabetes. Percent incidence 
of diabetes in each group on the ordinate was plotted against the age 
of recipient NOD mice in days on the abscissa. Time course of the in-
cidence of diabetes after the adoptive transfer of 2.0–6.0 3 106 cells of 
wild type Th1 clones plus CY (closed squares) and minus CY (closed 
triangles), PBS administration minus CY or CY administration alone 
(open squares), IL-10–transduced Th1 cells plus CY (open circles), or 
the 1:1 mixture of 2.0–3.0 3 106 cells each of wild type Th1 clones and 
IL-10–transduced Th1 cells plus CY (open triangles) is presented. 
Rectangles with arrows indicate the time of adoptive transfer at 8, 
non-fasting BG measurement at 35 and 47, and CY administration at 
37 d old. The incidence of diabetes started from 0 in all groups at age 
8 d and reached the ratio of the number of diabetic mice/the total 
number of examined mice at age 47 d as shown in parentheses.
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trast to its accelerating role for autoimmune diabetes in NOD
mice under its transgenic expression in islet A- or B-cells (28,
29). The present study was conducted to examine the role of
local IL-10, supplied through the adoptive transfer of IL-
10–transduced islet-specific Th1 clones (30) to neonatal NOD
mice, for the initiation of immunological destruction of islet
B-cells. These wild type islet-specific Th1 clones expressing
IFN-g mRNA (Fig. 1 A) were originally isolated from infiltrat-
ing lymphocytes in pancreatic islets of NOD mice. Their islet
specificity was retained by stimulating them with islet cells of
NOD mice as an Ag in vitro. The adoptive transfer of these
wild type Th1 clones with different TCR repertoires (30) to
NOD mice plus CY in our model triggered the advanced insu-
litis with the mean histological grade of 2.75 (Table II) and the
comparable incidence of diabetes in each clone resulting in
66% (23/35) in total (Fig. 6). CY alone never induced diabetes
in NOD mice (0/22), but the mean histological insulitis grade
of 0.98 after CY administration alone was higher than that of
0.48 (P , 0.0005) in control NOD mice. The adoptive transfer
of wild type Th1 clones minus CY induced diabetes in 5% (2/39)
with the mean histological grade of 1.85, which was even
higher than that of 0.98 after CY administration (P , 0.0005).
The adoptive transfer of IL-10–transduced Th1 cells plus
CY induced the low incidence of diabetes in 8% (1/12) and the
mean histological grade of insulitis of 1.43. In addition, the
adoptive transfer of the 1:1 mixture of wild type Th1 clones
and corresponding IL-10–transduced Th1 cells plus CY in-
duced the low incidence of diabetes in 20% (2/10) in total and
the mean histological grade of insulitis of 1.85 compared to
66% and 2.75 (P , 0.001), respectively, after the adoptive
transfer of wild type Th1 clones plus CY. The insertional mu-
tagenesis of Th1 clones after retroviral IL-10–transduction was
not regarded as the major factor for these suppressions for the
following two reasons. First, because the similar suppression in
the histological grade of insulitis and the incidence of diabetes
was observed by the adoptive transfer of the heterogeneous
IL-10–transduced Th1 cells without isolating IL-10–transduced
Th1 clones. Second, because the similar suppression of both
the histological grade of insulitis and the incidence of diabetes
was observed in the mixture experiments using two different
Th1 clones of D and G. The suppressed histological grade of
insulitis in association with the suppressed incidence of diabe-
tes after the adoptive transfer of not only IL-10–transduced
Th1 cells plus CY, but also the 1:1 mixture plus CY strongly
suggested that the expression of transduced IL-10 is responsi-
ble for their suppression. The slow induction of diabetes with
CY in our study is regarded due to the following reasons. First,
a single dose of CY of 200 mg/kg BW used in our experiment
was smaller than the total amount of 300 to 400 mg/kg BW of
CY in two divided doses separated by one or two weeks (35,
36), often used in other studies. Second, the earlier timing of
CY administration at age 37 d in our study than those used in
other studies, e.g., later than 10 wk old, explains the slow in-
duction, because CY administered at the earlier time points is
less effective in inducing diabetes in NOD mice (35, 36).
Because the neo gene was detected in the genomic DNA
extracted from recipient islets after the adoptive transfer of IL-
10–transduced Th1 cells (Fig. 5 B), the adoptively transferred
Th1 clones were shown to migrate and probably proliferate
around pancreatic islets. The expression of IL-10 mRNA after
the retroviral transduction of wild type Th1 clones was con-
firmed with RT-PCR (Figs. 1 B, 2 A). The genomic contamina-
tion was excluded firstly because primers were designed in
separate exons to cross an intron, and secondly because PCR-
products were not detected after omitting RTase from the re-
action mixture (Fig. 2 A). Because the retrovirus vector-medi-
Figure 7. Histology. Repre-
sentative hematoxylin and 
eosin-stained microscopic 
pictures (3 200) of recipient 
pancreatic islets at age 47 d 
are presented. (A and B) Se-
vere insulitis of grade 3 after 
the adoptive transfer of wild 
type Th1 clones plus CY. (C 
and D) Periinsulitis or insu-
litis of grade 1 after the 
adoptive transfer of IL-10–
transduced Th1 cells
plus CY.
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ated IL-10 mRNA was detected in isolated recipient islets
after the adoptive transfer of IL-10–transduced Th1 cells plus
CY (Fig. 2 B), the adoptively transferred IL-10–transduced
Th1 cells were shown to produce IL-10 in situ. The level of to-
tal IL-10 mRNA assessed by the RT-PCR cycle—30 necessary
to detect a band in recipient islets—was comparable, however,
after the adoptive transfer of wild type Th1 clones or IL-10–
transduced Th1 cells (Fig. 3 B). We regard the unchanged total
IL-10 mRNA in recipient islets to be mainly due to the assay
limit of RT-PCR that is not sensitive enough to detect a small
change in total IL-10 mRNA.
Although the IFN-g mRNA persisted in IL-10–transduced
Th1 cells in vitro (Fig. 1 B), its expression level was decreased,
which was reflected by the larger RT-PCR cycle number of 35
necessary to detect IFN-g mRNA, compared to that of 30 in
wild type Th1 clones (Fig. 3 A). In recipient islets after the
adoptive transfer of IL-10–transduced Th1 cells plus CY,
IFN-g mRNA became visible only after 35 cycles of RT-PCR,
while it was detected at as early as 30 cycles after the adoptive
transfer of wild type Th1 clones plus CY (Fig. 3 B). Despite
the limitation that the RT-PCR cycle number analysis gives
the semiquantitative measure of mRNA levels only, the IFN-g
mRNA level in vitro (Fig. 3 A), and the level of IFN-g mRNA
and its relative level to IL-10 mRNA in vivo (Fig. 3 B) were
both reproducibly decreased in the simultaneous assessment
of IL-10 and IFN-g mRNAs as reflected by the larger RT-PCR
cycle numbers.
We previously showed that IL-10 mRNA was detected af-
ter 35 cycles of RT-PCR in isolated pancreatic islets of NOD
mice over 5 wk old (28). In isolated pancreatic islets of NOD
mice, IL-10 and IFN-g mRNAs were detected with the semi-
quantitative RT-PCR cycle number analysis after 40 and 35 cy-
cles of PCR, respectively, both at age 5 and 8 wk (data not
shown). These results proved that IL-10 and IFN-g mRNAs
are produced in pancreatic islets in the natural course of islet
B-cell destruction in NOD mice. IL-10 that is produced not
only from adoptively transferred IL-10–transduced Th1 cells,
but also from the cellular components of recipient pancreatic
islets after their interaction with adoptively transferred wild or
IL-10–transduced Th1 lymphocytes, is expected to exhibit
their immunosuppressive function by decreasing IFN-g
mRNA relative to IL-10 mRNA through autocrine and para-
crine function of IL-10 without obviously changing the total
IL-10 mRNA. IL-10 secreted from IL-10–transduced Th1 cells
may have suppressed the immunological reactions not only in
pancreatic islets, but also in secondary lymphoid organs which
are the expected sites of action for the systemically adminis-
tered IL-10. Although the detailed mechanism is the subject of
our future study, the suppressed IFN-g production was as-
sumed to suppress the initiation process of autoimmune diabe-
tes through suppressing APCs to express MHC class II-associ-
ated antigens on their surface, leading to the suppression of
diabetes incidence to 5%.
The significant decrease in the mean histological grade of
insulitis after the adoptive transfer of IL-10–transduced Th1
cells plus CY or the 1:1 mixture plus CY in our study (Table II)
is compatible with the report by Katz et al. (37). Although
Th1- or Th2-like cells with the identical TCR efficiently accu-
mulated around pancreatic islets of NOD mice for the first few
days after the adoptive transfer, they reported that only Th1-
like cells actively promoted diabetes resulting in insulitis of all
islets, and that Th2-like cells, in contrast, did not progress be-
yond the periinsulitis stage. Th2-like cells, however, did not
provide protection against diabetes induced by Th1-like cells
in their study. The protective role of IL-10–transduced Th1
cells in our study is also compatible with the report by
Pennline et al. (18). They reported that the islets of NOD mice
after the systemic administration of IL-10 were surrounded,
but not infiltrated, by a small number of lymphocytes. Our his-
tological results together with these studies support the notion
that molecularly modified Th1 clones migrated to pancreatic
islets to produce IL-10, and also suppress insulitis and the inci-
dence of induced diabetes by wild type Th1 clones through
adoptive transfer.
The difference in transgenic (28, 29) and lymphocytic ex-
pression of IL-10 with the resulting acceleration and preven-
tion of diabetes, respectively, is assumed due to the difference
in expressing or responding cells, timing, and IL-10 concentra-
tions. Constitutive transgenic expression of IL-10 in islet A- or
B-cells during the development of islet cells even before birth,
induced prominent ductal proliferation, which was not repro-
duced by IL-10 expressed in Th1 lymphocytes to which islets
were exposed from age 8 to 47 d. The reversed effects of TNF-a
to induce or prevent diabetes in NOD mice depending on the
timing of its administration was reported by Yang et al. (38).
The local targeted delivery of IL-10 to islet-B cells through
the adoptive transfer of IL-10–transduced islet-specific Th1
lymphocytes in this study proved for the first time that IL-10–
transduced Th1 cells could deliver IL-10 to recipient islets ac-
cording to their TCR-specificity, and that they could suppress
the insulitis and immunological destruction of islet B-cells in
NOD mice through decreasing the relative level of IFN-g
mRNA to IL-10 mRNA in recipient islets. Adoptive transfer
of lymphocytes transduced with an immunosuppressive cyto-
kine gene is in a mirrored analogy to a somatic gene therapy
for melanomas using tumor-infiltrating lymphocytes trans-
duced with a cytotoxic TNF-a gene (39). This animal model af-
fords us the starting basis to develop the new concept of so-
matic gene therapy for autoimmune diabetes, in addition to
the transplantation of proinsulin-producing fibroblasts (40, 41).
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